Validation of the Italian version of the ANCA-associated vasculitis patient-reported outcome (AAV-PRO) questionnaire
© The Author(s) 2024. Published by Oxford University Press on behalf of the British Society for Rheumatology..
Objectives: The primary objective of this study was the translation and validation of the ANCA-associated vasculitis patient-reported outcome (AAV-PRO) questionnaire into Italian, denoted as AAV-PRO_ita. The secondary objective was to evaluate the impact of ANCA-associated vasculitis (AAV) on quality of life (QoL) and work impairment in a large cohort of Italian patients.
Methods: The study design took a prospective cohort study approach. First, the AAV-PRO was translated into Italian following the step guidelines for translations. The new AAV-PRO_ita questionnaire covered three disease domains: organ-specific and systemic symptoms and signs; physical function; and social and emotional impact. Second, Italian-speaking AAV patients were recruited from 17 Italian centres belonging to the Italian Vasculitis Study Group. Participants completed the AAV-PRO_ita questionnaire at three time points. Participants were also requested to complete the work productivity and activity impairment: general health questionnaire.
Results: A total of 276 AAV patients (56.5% women) completed the questionnaires. The AAV-PRO_ita questionnaire demonstrated a good internal consistency and test-retest reliability. Female AAV patients scored higher (i.e. worse) in all thee domains, especially in the social and emotional impact domain (P < 0.001). Patients on glucocorticoid therapy (n = 199) had higher scores in all domains, especially in the physical function domain (P < 0.001), compared with patients not on glucocorticoid therapy (n = 77). Furthermore, patients who had at least one relapse of disease (n = 114) had higher scores compared with those who had never had one (n = 161) in any domain (P < 0.05). Finally, nearly 30% of the patients reported work impairment.
Conclusion: The AAV-PRO_ita questionnaire is a new 29-item, disease-specific patient-reported outcome measuring tool that can be used in AAV research in the Italian language. Sex, glucocorticoids and relapsing disease showed the greatest impact on QoL.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2024 |
|---|---|
| Erschienen: |
2024 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:8 |
|---|---|
| Enthalten in: |
Rheumatology advances in practice - 8(2024), 1 vom: 12., Seite rkae001 |
| Sprache: |
Englisch |
|---|
| Links: |
|---|
| Themen: |
AAV-PRO |
|---|
| Anmerkungen: |
Date Revised 23.03.2024 published: Electronic-eCollection Citation Status PubMed-not-MEDLINE |
|---|
| doi: |
10.1093/rap/rkae001 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM370051548 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM370051548 | ||
| 003 | DE-627 | ||
| 005 | 20240323235709.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 240323s2024 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1093/rap/rkae001 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1342.xml |
| 035 | |a (DE-627)NLM370051548 | ||
| 035 | |a (NLM)38515585 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Treppo, Elena |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Validation of the Italian version of the ANCA-associated vasculitis patient-reported outcome (AAV-PRO) questionnaire |
| 264 | 1 | |c 2024 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Revised 23.03.2024 | ||
| 500 | |a published: Electronic-eCollection | ||
| 500 | |a Citation Status PubMed-not-MEDLINE | ||
| 520 | |a © The Author(s) 2024. Published by Oxford University Press on behalf of the British Society for Rheumatology. | ||
| 520 | |a Objectives: The primary objective of this study was the translation and validation of the ANCA-associated vasculitis patient-reported outcome (AAV-PRO) questionnaire into Italian, denoted as AAV-PRO_ita. The secondary objective was to evaluate the impact of ANCA-associated vasculitis (AAV) on quality of life (QoL) and work impairment in a large cohort of Italian patients | ||
| 520 | |a Methods: The study design took a prospective cohort study approach. First, the AAV-PRO was translated into Italian following the step guidelines for translations. The new AAV-PRO_ita questionnaire covered three disease domains: organ-specific and systemic symptoms and signs; physical function; and social and emotional impact. Second, Italian-speaking AAV patients were recruited from 17 Italian centres belonging to the Italian Vasculitis Study Group. Participants completed the AAV-PRO_ita questionnaire at three time points. Participants were also requested to complete the work productivity and activity impairment: general health questionnaire | ||
| 520 | |a Results: A total of 276 AAV patients (56.5% women) completed the questionnaires. The AAV-PRO_ita questionnaire demonstrated a good internal consistency and test-retest reliability. Female AAV patients scored higher (i.e. worse) in all thee domains, especially in the social and emotional impact domain (P < 0.001). Patients on glucocorticoid therapy (n = 199) had higher scores in all domains, especially in the physical function domain (P < 0.001), compared with patients not on glucocorticoid therapy (n = 77). Furthermore, patients who had at least one relapse of disease (n = 114) had higher scores compared with those who had never had one (n = 161) in any domain (P < 0.05). Finally, nearly 30% of the patients reported work impairment | ||
| 520 | |a Conclusion: The AAV-PRO_ita questionnaire is a new 29-item, disease-specific patient-reported outcome measuring tool that can be used in AAV research in the Italian language. Sex, glucocorticoids and relapsing disease showed the greatest impact on QoL | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a AAV-PRO | |
| 650 | 4 | |a ANCA | |
| 650 | 4 | |a glucocorticoids | |
| 650 | 4 | |a patient-reported outcome | |
| 650 | 4 | |a quality of life | |
| 650 | 4 | |a questionnaire | |
| 650 | 4 | |a vasculitis | |
| 650 | 4 | |a work impairment | |
| 700 | 1 | |a Isola, Miriam |e verfasserin |4 aut | |
| 700 | 1 | |a De Martino, Maria |e verfasserin |4 aut | |
| 700 | 1 | |a Padoan, Roberto |e verfasserin |4 aut | |
| 700 | 1 | |a Giollo, Alessandro |e verfasserin |4 aut | |
| 700 | 1 | |a Urban, Maria Letizia |e verfasserin |4 aut | |
| 700 | 1 | |a Monti, Sara |e verfasserin |4 aut | |
| 700 | 1 | |a Sartorelli, Silvia |e verfasserin |4 aut | |
| 700 | 1 | |a Fassio, Angelo |e verfasserin |4 aut | |
| 700 | 1 | |a Argolini, Lorenza Maria |e verfasserin |4 aut | |
| 700 | 1 | |a Marvisi, Chiara |e verfasserin |4 aut | |
| 700 | 1 | |a Gattamelata, Angelica |e verfasserin |4 aut | |
| 700 | 1 | |a Regola, Francesca |e verfasserin |4 aut | |
| 700 | 1 | |a Ferro, Francesco |e verfasserin |4 aut | |
| 700 | 1 | |a Cassone, Giulia |e verfasserin |4 aut | |
| 700 | 1 | |a Motta, Francesca |e verfasserin |4 aut | |
| 700 | 1 | |a Berti, Alvise |e verfasserin |4 aut | |
| 700 | 1 | |a Conticini, Edoardo |e verfasserin |4 aut | |
| 700 | 1 | |a Guiducci, Serena |e verfasserin |4 aut | |
| 700 | 1 | |a Matucci-Cerinic, Marco |e verfasserin |4 aut | |
| 700 | 1 | |a Lo Gullo, Alberto |e verfasserin |4 aut | |
| 700 | 1 | |a Manfredi, Andreina |e verfasserin |4 aut | |
| 700 | 1 | |a Frediani, Bruno |e verfasserin |4 aut | |
| 700 | 1 | |a Bortolotti, Roberto |e verfasserin |4 aut | |
| 700 | 1 | |a Selmi, Carlo |e verfasserin |4 aut | |
| 700 | 1 | |a Baldini, Chiara |e verfasserin |4 aut | |
| 700 | 1 | |a Franceschini, Franco |e verfasserin |4 aut | |
| 700 | 1 | |a Conti, Fabrizio |e verfasserin |4 aut | |
| 700 | 1 | |a Caporali, Roberto |e verfasserin |4 aut | |
| 700 | 1 | |a Rossini, Maurizio |e verfasserin |4 aut | |
| 700 | 1 | |a Dagna, Lorenzo |e verfasserin |4 aut | |
| 700 | 1 | |a Montecucco, Carlomaurizio |e verfasserin |4 aut | |
| 700 | 1 | |a Emmi, Giacomo |e verfasserin |4 aut | |
| 700 | 1 | |a Schiavon, Franco |e verfasserin |4 aut | |
| 700 | 1 | |a Salvarani, Carlo |e verfasserin |4 aut | |
| 700 | 1 | |a Quartuccio, Luca |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Rheumatology advances in practice |d 2017 |g 8(2024), 1 vom: 12., Seite rkae001 |w (DE-627)NLM291368786 |x 2514-1775 |7 nnns |
| 773 | 1 | 8 | |g volume:8 |g year:2024 |g number:1 |g day:12 |g pages:rkae001 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1093/rap/rkae001 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 8 |j 2024 |e 1 |b 12 |h rkae001 | ||